RAJAF (Cordyceps Sunshine Biotech Holdings Co) Total Stockholders Equity : $-0.08 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cordyceps Sunshine Biotech Holdings Co Total Stockholders Equity?

Cordyceps Sunshine Biotech Holdings Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-0.08 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Cordyceps Sunshine Biotech Holdings Co's Book Value per Share for the quarter that ended in Dec. 2023 was $-0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Cordyceps Sunshine Biotech Holdings Co's Debt-to-Equity for the quarter that ended in Dec. 2023 was -8.58.

Cordyceps Sunshine Biotech Holdings Co Total Stockholders Equity Historical Data

The historical data trend for Cordyceps Sunshine Biotech Holdings Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cordyceps Sunshine Biotech Holdings Co Total Stockholders Equity Chart

Cordyceps Sunshine Biotech Holdings Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

-0.01

-0.28

-0.95

-0.08

Cordyceps Sunshine Biotech Holdings Co Quarterly Data
	Dec20	Dec21	Dec22	Sep23	Dec23
Total Stockholders Equity	-0.01	-0.28	-0.95	-0.18	-0.08

Cordyceps Sunshine Biotech Holdings Co (OTCPK:RAJAF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Cordyceps Sunshine Biotech Holdings Co's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-0.079	-	0)	/	111.120
	=	-0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Cordyceps Sunshine Biotech Holdings Co's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.106	+	0.572)	/	-0.079
	=	-8.58

Cordyceps Sunshine Biotech Holdings Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Cordyceps Sunshine Biotech Holdings Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cordyceps Sunshine Biotech Holdings Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Cordyceps Sunshine Biotech Holdings Co Ltd (OTCPK:RAJAF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 548, Ruiguang Road, 6th Floor, No. 15, Neihu District, Taipei City, TWN

Website

http://www.cordyceps-sunshine.com

Cordyceps Sunshine Biotech Holdings Co Ltd engages in cultivating Chinese rare medicinal herbs, Cattle camphor mushroom raw materials, and selling its finished products. The company has one business segment: cultivating and sales of Chinese rare medicinal herb, taiwanofungus raw material, and its finished products. The company generates revenue from product sales, training, and related parties.

Cordyceps Sunshine Biotech Holdings Co Headlines

No Headlines